Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
3.200
-0.180 (-5.33%)
At close: Sep 10, 2025
EGX:MCRO Revenue
Macro Group Pharmaceuticals (Macro Capital) S.A.E had revenue of 227.15M EGP in the quarter ending June 30, 2025, with 137.32% growth. This brings the company's revenue in the last twelve months to 776.26M, up 125.64% year-over-year. In the year 2024, Macro Group Pharmaceuticals (Macro Capital) S.A.E had annual revenue of 519.97M, down -1.15%.
Revenue (ttm)
776.26M
Revenue Growth
+125.64%
P/S Ratio
2.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 519.97M | -6.04M | -1.15% |
Dec 31, 2023 | 526.01M | -203.61M | -27.91% |
Dec 31, 2022 | 729.61M | 135.35M | 22.78% |
Dec 31, 2021 | 594.26M | 163.76M | 38.04% |
Dec 31, 2020 | 430.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Commercial International Bank Egypt (CIB) S.A.E. | 111.86B |
El Sewedy Electric Company | 253.16B |
Eastern Company S.A.E | 34.08B |
Talaat Moustafa Group Holding | 50.04B |
Misr Fertilizer Production Company | 23.05B |
Telecom Egypt Company | 94.68B |
Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.) | 22.92B |
Egypt Aluminum | 42.42B |